Press releases
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People
More ▼
Key statistics
On Thursday, Dexcom Inc (0A4M:LSE) closed at 136.49, -3.86% below its 52-week high of 141.97, set on Apr 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | 82.40 |
Offer | 552.40 |
Previous close | 137.51 |
Average volume | 6.42k |
---|---|
Shares outstanding | 396.03m |
Free float | 384.10m |
P/E (TTM) | 107.54 |
Market cap | 54.60bn USD |
EPS (TTM) | 1.28 USD |
Data delayed at least 20 minutes, as of Apr 25 2024 17:36 BST.
More ▼